top

  Info

  • Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.

  Info

  • Utilizzare questo link per rimuovere la selezione effettuata.
Antitumoral Properties of Natural Products : Volume 2
Antitumoral Properties of Natural Products : Volume 2
Autore Fabiani Roberto
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Descrizione fisica 1 online resource (300 p.)
Soggetto topico Biology, life sciences
Research & information: general
Soggetto non controllato 13-ethylberberine
Akt
AKT
anthraquinones
anti-cancer
anti-cancer activity
anti-cancer agents
anti-tumor activity
anticancer
Antioxidant activities
antioxidants
antioxidation
antiproliferation agents
Antiproliferative
antiproliferative activity
antitumoral activity
antrodin C
apoptosis
AR
Artemisia absinthium
ASE
Aspergillus fumigatus
ATM-Chk2
autophagic flux inhibition
autophagy
bee venom
betulinic acid
Brazilian Cerrado biome
cancer
cancer stem cells
capsazepine
carrageenan
Catalpa speciosa
Celastraceae
cell cycle arrest
cell proliferation
cell signaling
cephalotaxine
cervical cancer
Cheiloclinium cognatum
chemotherapeutic adjuvant
chemotherapy
chiral resolution
CIP2A
CLE-10
CLEFMA
Colocasia esculenta
colorectal cancer cells
copper
Cordyceps sinensis
coronarin D
CrataBL
cryptolepine
Cucurbitacin B
cytotoxic activity
cytotoxicity
Dendrobium officinale
diallyl disulfide
dicentrine
DLD-1 cells
doxorubicin
drug resistance
ECD calculation
EGFR
endoplasmic reticulum stress
entrapment efficiency
Euphorbia tirucalli
FAK/S6K1
flavonoids
folk medicine
food bioactive
FOXO1
fruit
Ganoderma tsugae
gastric cancer
gastric cancer cells
gefitinib-resistant NSCLC
Gene expression
glioblastoma
glioblastoma multiforme
glioma
glucose uptake
glycosyltransferase
grape leaves
human neuroblastoma cells
IL-6/JAK2/STAT3
inflammation
inflammatory diseases
ingenol
invasion
isochromanes
isocryptolepine
JNK
lactoferrin hydrolysate
LC3
lichen
Licochalcone A
lipogenesis
lung adenocarcinoma
lysosomal degradation
lysosomal membrane permeabilization
Magnolia acuminata
manganese
MAPK
MCF-7 cells
MDA-MB-231
melanoma
melittin
mesenchymal stem cells
metabolic stability
metastasis
microenvironment
migration
mitochondrial membrane potential
mitochondrial ROS
mitochondrial-dependent pathway
molecular mechanism
mTOR
multiple myeloma
n/a
naringenin
natural compounds
natural product alkaloids
natural products
natural yellow Monascus pigments
NCI-60 cancer cell line
necrotic
neferine
neocryptolepine
NF-κB
no-toxicity
Nutraceuticals
oncogene
osteosarcoma
p38
patuletin
phenols
phloretin
phytochemicals
PI3K/AKT/mTOR
PI3K/Akt/mTOR pathway
plant lectin
plant-derived foods
plantation mode
Plenckia populnea
porphyran
preclinical tests
pristimerin
pro-apoptotic effects
proanthocyanins
prostate cancer
protease inhibitor
protein kinase C
protein synthesis inhibition
Pulsatilla saponin D
quality control
quercetagetin
quercetin
ROS
RT-R breast cancer cells
Salacia crassifolia
Salacia elliptica
SB365
seaweed
secondary metabolites
semi-synthetic derivative
SREBP-1
stable nanocapsules
stemness potential
structure activity relationships
structure elucidation
tarin
Taxus cuspidata
temozolomide
TNF-α
TP
traditional preparation
transcriptional regulation
triterpenoids
TRPV1
tumidulin
ursolic acid
vegetable
water-soluble
zerumbone
Zeylenone
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti Antitumoral Properties of Natural Products
Record Nr. UNINA-9910557531303321
Fabiani Roberto  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Antitumoral Properties of Natural Products
Antitumoral Properties of Natural Products
Autore Fabiani Roberto
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Descrizione fisica 1 online resource (344 p.)
Soggetto topico Biology, life sciences
Research & information: general
Soggetto non controllato 13-ethylberberine
Akt
AKT
anthraquinones
anti-cancer
anti-cancer activity
anti-cancer agents
anti-tumor activity
anticancer
Antioxidant activities
antioxidants
antioxidation
antiproliferation agents
Antiproliferative
antiproliferative activity
antitumoral activity
antrodin C
apoptosis
AR
Artemisia absinthium
ASE
Aspergillus fumigatus
ATM-Chk2
autophagic flux inhibition
autophagy
bee venom
betulinic acid
Brazilian Cerrado biome
cancer
cancer stem cells
capsazepine
carrageenan
Catalpa speciosa
Celastraceae
cell cycle arrest
cell proliferation
cell signaling
cephalotaxine
cervical cancer
Cheiloclinium cognatum
chemotherapeutic adjuvant
chemotherapy
chiral resolution
CIP2A
CLE-10
CLEFMA
Colocasia esculenta
colorectal cancer cells
copper
Cordyceps sinensis
coronarin D
CrataBL
cryptolepine
Cucurbitacin B
cytotoxic activity
cytotoxicity
Dendrobium officinale
diallyl disulfide
dicentrine
DLD-1 cells
doxorubicin
drug resistance
ECD calculation
EGFR
endoplasmic reticulum stress
entrapment efficiency
Euphorbia tirucalli
FAK/S6K1
flavonoids
folk medicine
food bioactive
FOXO1
fruit
Ganoderma tsugae
gastric cancer
gastric cancer cells
gefitinib-resistant NSCLC
Gene expression
glioblastoma
glioblastoma multiforme
glioma
glucose uptake
glycosyltransferase
grape leaves
human neuroblastoma cells
IL-6/JAK2/STAT3
inflammation
inflammatory diseases
ingenol
invasion
isochromanes
isocryptolepine
JNK
lactoferrin hydrolysate
LC3
lichen
Licochalcone A
lipogenesis
lung adenocarcinoma
lysosomal degradation
lysosomal membrane permeabilization
Magnolia acuminata
manganese
MAPK
MCF-7 cells
MDA-MB-231
melanoma
melittin
mesenchymal stem cells
metabolic stability
metastasis
microenvironment
migration
mitochondrial membrane potential
mitochondrial ROS
mitochondrial-dependent pathway
molecular mechanism
mTOR
multiple myeloma
n/a
naringenin
natural compounds
natural product alkaloids
natural products
natural yellow Monascus pigments
NCI-60 cancer cell line
necrotic
neferine
neocryptolepine
NF-κB
no-toxicity
Nutraceuticals
oncogene
osteosarcoma
p38
patuletin
phenols
phloretin
phytochemicals
PI3K/AKT/mTOR
PI3K/Akt/mTOR pathway
plant lectin
plant-derived foods
plantation mode
Plenckia populnea
porphyran
preclinical tests
pristimerin
pro-apoptotic effects
proanthocyanins
prostate cancer
protease inhibitor
protein kinase C
protein synthesis inhibition
Pulsatilla saponin D
quality control
quercetagetin
quercetin
ROS
RT-R breast cancer cells
Salacia crassifolia
Salacia elliptica
SB365
seaweed
secondary metabolites
semi-synthetic derivative
SREBP-1
stable nanocapsules
stemness potential
structure activity relationships
structure elucidation
tarin
Taxus cuspidata
temozolomide
TNF-α
TP
traditional preparation
transcriptional regulation
triterpenoids
TRPV1
tumidulin
ursolic acid
vegetable
water-soluble
zerumbone
Zeylenone
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557419703321
Fabiani Roberto  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Circulating Tumor Cells: Finding Rare Events for A Huge Knowledge of Cancer Dissemination
Circulating Tumor Cells: Finding Rare Events for A Huge Knowledge of Cancer Dissemination
Autore Alix-Panabieres Catherine
Pubbl/distr/stampa MDPI - Multidisciplinary Digital Publishing Institute, 2020
Descrizione fisica 1 online resource (366 p.)
Soggetto topico Medicine and Nursing
Soggetto non controllato abiraterone
ACCEPT
androgen receptor
AR
AR-V7
ARV7
biomarker
biomarkers
bone marrow
breast cancer
castration resistant prostate cancer (CRPC)
CD133
CellSearch
CellSearch®
cerebrospinal liquid biopsy
chemoradioresistance
chromogranin A
circulating leukemia cells
circulating plasma cells
circulating tumor cells
circulating tumor cells (CTC)
circulating tumor cells (CTCs)
circulating tumor DNA
circulating tumour cells
clinical trials
clinical utility
colorectal cancer
colorectal surgery
CTC
CTC biology
CTC capture technology
CTC-based treatment decisions
CTC-derived ex vivo models
CTC-derived xenografts
CTCs
ctDNA
CTM
CTMat
ctRNA
disseminated tumor cells
early breast cancer
EasyCount slides
emboli
enrichment and detection technologies
enzalutamide
EpCAM enrichment
EPISPOT
epithelial-mesenchymal transition
epithelial-to-mesenchymal transition (EMT)
exosome
exosomes
fibronectin
fish
flow cytometry
FOLFIRINOX
gene expression analysis
glioma
hematological cells
hepatocellular carcinoma (HCC)
heterogeneity
HMB-45
immune checkpoint inhibitors
immune system
immunofluorescence imaging
immunomodulation
immunophenotyping
in vivo flow cytometry
integrin B1
leukocyte-derived extracellular vesicles
liquid biopsy
liquid surgery
locally advanced rectal cancer
major histocompatibility complex class I (MHCI)
malaria
melanoma
metastasis
metastatic colorectal cancer
microbiome
microfluidics
microsatellite instability
miRNA
n/a
neutrophils
NSCLC
PD-L1 expression
platelets
prostate cancer
prostate cancer (PCa)
RAD23B
rovalpituzumab tesirine
rVAR2
single-cell analysis
SLUG
small-cell lung carcinoma
solid cancers
stem cells
synaptophysin
targeted therapy
thymidylate synthase
tumor biomarkers
tumor cell dissemination
tumor stem cells
tumor-initiating cells (TICs)
xenograft models
ISBN 3-03928-699-4
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti Circulating Tumor Cells
Record Nr. UNINA-9910404091403321
Alix-Panabieres Catherine  
MDPI - Multidisciplinary Digital Publishing Institute, 2020
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
New Prognostic and Predictive Markers in Cancer Progression
New Prognostic and Predictive Markers in Cancer Progression
Autore Costantini Susan
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Descrizione fisica 1 online resource (294 p.)
Soggetto topico Medicine and Nursing
Soggetto non controllato acetyltransferase
AKT
antigen processing machinery (APM) molecules
AR
biomarker
biomarkers
bladder cancer
blood
BRCA1/2
breast cancer
cancer
cancer immunotherapy
cancer prognosis
carcinogenesis
cardioncology
cardiotoxicity
castration-resistant prostate cancer (CRPC)
CD8+ T effector cells
chemo-/radio resistance
CSC
CTCs
cytokines
EMT
eribulin
genetic syndromes
genomic mutations
head and neck cancer
head and neck neoplasms
head and neck tumors
HRR
HUB nodes
human leukocyte antigen (HLA)
hyperglycemia
immune checkpoint inhibitor
K-RAS oncogene
laryngeal cancer
lifestyle habit
major histocompatibility complex (MHC)
MAPK
melanoma
melanoma resistance to MAPK/MEK inhibitors
metabolomics
metastasis
microRNA
miRNA
MSI2
mTOR
musashi 2
mutations
N-cadherin
n/a
NAA10
new metastasis
nivolumab
oncogene dependency
oral cancer
OSCC
pancreatic cancer
paraganglioma
PDL1
pheochromocytoma
PI3K
PI3KCA
prediction
prognosis
prostate cancer
PTEN
resistance to immune checkpoint inhibitors
selenoproteins
targeted therapies
therapeutic resistance
therapeutic target
TILs
TNBC
transcriptomics
tumor predisposition
WNT
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557794803321
Costantini Susan  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui